Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
Orlandi E, Bonomo P, Ferella L, D'Angelo E, Maddalo M, Alterio D, Infante G, Bacigalupo A, Argenone A, Iacovelli NA, Desideri I, Meduri B, Triggiani L, Volpe S, Belgioia L, Dionisi F, Romanello DA, Fallai C, Miceli R. Orlandi E, et al. Among authors: meduri b. Head Neck. 2019 Oct;41(10):3684-3692. doi: 10.1002/hed.25890. Epub 2019 Jul 29. Head Neck. 2019. PMID: 31355972
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Meattini I, Pasinetti N, Meduri B, De Rose F, De Santis MC, Franco P, Lancellotta V, Rossi F, Saieva C, Desideri I, Delli Paoli C, D'Angelo E, Triggiani L, Bastiani P, Alongi F, Lozza L, Aristei C, Ricardi U, Scorsetti M, Livi L; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Meattini I, et al. Among authors: meduri b. Radiother Oncol. 2019 Feb;131:208-214. doi: 10.1016/j.radonc.2018.07.015. Epub 2018 Jul 31. Radiother Oncol. 2019. PMID: 30075864 Free article.
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.
Pedretti S, Masini L, Turco E, Triggiani L, Krengli M, Meduri B, Pirtoli L, Borghetti P, Pegurri L, Riva N, Gatta R, Fusco V, Scoccianti S, Bruni A, Ricardi U, Santoni R, Magrini SM, Buglione M. Pedretti S, et al. Among authors: meduri b. J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4. J Neurooncol. 2019. PMID: 31054101 Clinical Trial.
Local Treatment of the Axilla in Early Breast Cancer: So Many Questions, Still Few Answers.
Meattini I, De Santis MC, De Rose F, Desideri I, Franco P, Kaidar-Person O, Meduri B, Pasinetti N, Lancellotta V; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Meattini I, et al. Among authors: meduri b. Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e37-e38. doi: 10.1016/j.clon.2019.08.001. Epub 2019 Aug 14. Clin Oncol (R Coll Radiol). 2020. PMID: 31421912 No abstract available.
Volume de-escalation in radiation therapy: state of the art and new perspectives.
Meduri B, Gregucci F, D'Angelo E, Alitto AR, Ciurlia E, Desideri I, Marino L, Borghetti P, Fiore M, Fiorentino A; AIRO Giovani -Italian Association of Radiation Oncology-Young Members. Meduri B, et al. J Cancer Res Clin Oncol. 2020 Apr;146(4):909-924. doi: 10.1007/s00432-020-03152-7. Epub 2020 Feb 18. J Cancer Res Clin Oncol. 2020. PMID: 32072318 Review.
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F, De Santis MC, Meduri B, Franzese C, Franceschini D, Franco P, Pasinetti N, Lancellotta V, Giacobazzi P, La Rocca E, D'Angelo E, Lozza L, Livi L, Meattini I, Scorsetti M. De Rose F, et al. Among authors: meduri b. J Cancer Res Clin Oncol. 2021 Jul;147(7):2069-2077. doi: 10.1007/s00432-020-03483-5. Epub 2021 Jan 2. J Cancer Res Clin Oncol. 2021. PMID: 33387035
Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO).
Marino L, Lancellotta V, Franco P, Meattini I, Meduri B, Bernini M, Fabi A, Corvò R, Magrini SM, Pappagallo GL, Arcangeli S, D'Angelillo RM. Marino L, et al. Among authors: meduri b. Breast. 2021 Feb;55:119-127. doi: 10.1016/j.breast.2020.12.012. Epub 2021 Jan 2. Breast. 2021. PMID: 33445150 Free PMC article. Review.
129 results